By Josh Beckerman UCB agreed to buy Neurona Therapeutics for up to $1.15 billion, a deal that would add potential epilepsy drug NRTX-1001 to the Belgian company's portfolio. The agreement...
UCB to Buy Neurona Therapeutics for Up to $1.15 Billion
By Josh Beckerman UCB agreed to buy Neurona Therapeutics for up to $1.15 billion, a deal that would add potential epilepsy drug NRTX-1001 to the Belgian company's portfolio. The agreement...